Summary
Brian Kim is a physician-scientist, entrepreneur, and co-founder with 11 years of experience translating neuroimmunology research into targeted therapies for inflammatory and sensory skin disorders. As Vice Chair of Research and Director of the Mark Lebwohl Center at Mount Sinai, he leads NIH-funded basic, translational, and clinical programs that connect barrier biology, neuroimmune mechanisms, and patient care. He has founded multiple biotech ventures, including Alys Pharmaceuticals and KliRNA Biotech, to advance neuroimmunomodulatory and siRNA-based anti-itch therapeutics. Trained as an MD with postgraduate research at institutions including Penn and NIH, he blends deep clinical insight with hands-on laboratory and startup leadership. Notably, his work focuses on reframing immunity through neuroimmune principles—pursuing therapies that target sensation and inflammation rather than conventional immune-only approaches.
11 years of coding experience
8 years of employment as a software developer
Masters in Translational Research (M.T.R.), Translational Research, Masters in Translational Research (M.T.R.), Translational Research at University of Pennsylvania School of Medicine
Bachelor of Science (B.S.), Chemistry, Bachelor of Science (B.S.), Chemistry at Haverford College
Doctorate of Medicine (M.D.), Medicine, Doctorate of Medicine (M.D.), Medicine at University of Washington School of Medicine
English